Frequently Asked Questions
Is NuvaPro™ safe to be taken during pregnancy?
Lactobacillus fermentum PCC® as contained in NuvaPro® has been proven to be a probiotic which means that it is a bacteria which brings benefit to the host.
According to the National Library of Medicine (NLM) and the National Institute of Health (NIH), probiotics are probably safe because current data indicates probiotic supplements are rarely absorbed. The likelihood of contracting bacteremia from taking Lactobacillus probiotics is less than 1 per 1 million.
In the limited research on probiotic use during pregnancy, there have been no associations with probiotic use and miscarriages or malformations of any kind. Furthermore, a meta-analysis by Canadian researchers found no association with probiotic use and the incidence of Caesarean section, birth weight, or gestational age.
The NLM and NIH concluded there does not appear to be any risk of probiotic use for expecting, or lactating mothers.
Do I need to keep NuvaPro™ in the fridge?
NuvaPro™ is a hardy probiotic and has been shown to be stable at room temepratures of 25OC hence it does not require a cold chain. To maintain the viability of this live microorganism, we recommend that it be kept in the fridge or freezer until required for use once purchased. This powder will not freeze even though stored in the freezer.
I was told that each 2g sachet of NuvaPro™ contains a guaranteed 2 billion cfu count until the end of its shelf life. Isn’t this a low cfu count compared to other probiotics?
Each probiotic has to be evaluated based on its effective dose as utilised in clinical studies. One particular strain of probiotics may be effective at 10 billion cfu whilst another strain may be effective utilising just 1 billion cfu. Each strain has a specific strength to which it is effective just like how some antibiotics work at doses of 1,500mg per day whilst others require a strength of only 250mg per day.
Upon input, approximately 30 billion of PCC® is filled into in each 2g sachet. NuvaPro™ guarantees that there will be at least 2 billion at the end of its shelf life (24 months). Doses used in clinical studies are based on a 2 billion PCC® cfu count per dose.